Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 44

1.

DEFINING ELIGIBILITY CRITERIA FOR FUNDING POLICIES AROUND IN VITRO FERTILIZATION.

Menon D, Nardelli AA, Motan T, Klein K, Stafinski T.

Int J Technol Assess Health Care. 2015 Jan;31(6):426-33. doi: 10.1017/S0266462315000628. Epub 2015 Dec 30.

PMID:
26715584
2.

Assisted Reproductive Technologies in Alberta: An Economic Analysis to Inform Policy Decision-Making.

Vaidya A, Stafinski T, Nardelli A, Motan T, Menon D.

J Obstet Gynaecol Can. 2015 Dec;37(12):1122-30.

PMID:
26637087
3.

Reimbursement of Drugs for Rare Diseases through the Public Healthcare System in Canada: Where Are We Now?

Menon D, Clark D, Stafinski T.

Healthc Policy. 2015 Aug;11(1):15-32.

PMID:
26571466
4.

Introduction of a new health technology into a provincial health system: A case study of insulin pump therapy.

Menon D, Stafinski T, Nardelli A, Edwards A.

Healthc Manage Forum. 2015 Sep;28(5):210-4. doi: 10.1177/0840470415598328. Epub 2015 Jul 29. Review.

PMID:
26227318
5.
6.

Developing a patient-directed policy framework for managing orphan and ultra-orphan drugs throughout their lifecycle.

Menon D, Stafinski T, Dunn A, Wong-Rieger D.

Patient. 2015 Feb;8(1):103-17. doi: 10.1007/s40271-014-0108-6.

7.

Involving patients in reducing decision uncertainties around orphan and ultra-orphan drugs: a rare opportunity?

Menon D, Stafinski T, Dunn A, Short H.

Patient. 2015 Feb;8(1):29-39. doi: 10.1007/s40271-014-0106-8.

PMID:
25516506
8.

Incorporating patient preferences into clinical trial design: results of the opinions of patients on treatment implications of new studies (OPTIONS) project.

Stafinski T, Menon D, Nardelli A, Bakal J, Ezekowitz J, Tymchak W, Welsh R, Gyenes G, Armstrong PW.

Am Heart J. 2015 Jan;169(1):122-31.e22. doi: 10.1016/j.ahj.2014.10.002. Epub 2014 Oct 13.

PMID:
25497257
9.

Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework.

Paulden M, Stafinski T, Menon D, McCabe C.

Pharmacoeconomics. 2015 Mar;33(3):255-69. doi: 10.1007/s40273-014-0235-x.

10.

Assisted reproductive technologies (ARTs): evaluation of evidence to support public policy development.

Nardelli AA, Stafinski T, Motan T, Klein K, Menon D.

Reprod Health. 2014 Nov 7;11(1):76. doi: 10.1186/1742-4755-11-76. Review.

11.

Transparency in reimbursement decisions: in whose best interest?

Stafinski T, Menon D.

Pharmacoeconomics. 2014 Aug;32(8):725-7. doi: 10.1007/s40273-014-0176-4. No abstract available.

PMID:
24866390
12.

Barriers and facilitators to evidence-use in program management: a systematic review of the literature.

Humphries S, Stafinski T, Mumtaz Z, Menon D.

BMC Health Serv Res. 2014 Apr 14;14:171. doi: 10.1186/1472-6963-14-171. Review.

13.

An international survey of assisted reproductive technologies (ARTs) policies and the effects of these policies on costs, utilization, and health outcomes.

Dunn AL, Stafinski T, Menon D.

Health Policy. 2014 Jun;116(2-3):238-63. doi: 10.1016/j.healthpol.2014.03.006. Epub 2014 Mar 15. Review.

PMID:
24698476
14.

Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature.

Klein KB, Stafinski TD, Menon D.

PLoS One. 2013 Dec 12;8(12):e80661. doi: 10.1371/journal.pone.0080661. eCollection 2013. Review.

15.

Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis.

El Shayeb M, Topfer LA, Stafinski T, Pawluk L, Menon D.

CMAJ. 2014 Jan 7;186(1):E25-51. doi: 10.1503/cmaj.130952. Epub 2013 Nov 11. Review.

16.

A systematic review of the safety and effectiveness of fully implantable middle ear hearing devices: the carina and esteem systems.

Klein K, Nardelli A, Stafinski T.

Otol Neurotol. 2012 Aug;33(6):916-21. doi: 10.1097/MAO.0b013e31825f230d. Review.

PMID:
22772013
17.

Assessing the impact of deliberative processes on the views of participants: is it 'in one ear and out the other'?

Stafinski T, Menon D, Yasui Y.

Health Expect. 2014 Apr;17(2):278-90. doi: 10.1111/j.1369-7625.2011.00749.x. Epub 2012 Feb 2.

PMID:
22296492
18.

Role of centralized review processes for making reimbursement decisions on new health technologies in Europe.

Stafinski T, Menon D, Davis C, McCabe C.

Clinicoecon Outcomes Res. 2011;3:117-86. doi: 10.2147/CEOR.S14407. Epub 2011 Aug 30.

19.

Access with evidence development: an approach to introducing promising new technologies into healthcare.

Menon D, Stafinski T, Nardelli A, Jackson T, Jhamandas J.

Healthc Manage Forum. 2011 Summer;24(2):42-56. English, French.

PMID:
21899224
20.

Societal values in the allocation of healthcare resources: is it all about the health gain?

Stafinski T, Menon D, Marshall D, Caulfield T.

Patient. 2011;4(4):207-25. doi: 10.2165/11588880-000000000-00000. Review.

PMID:
21815706
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk